Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 29

    Strides Pharma arm gets tentative USFDA nod for skin ointment

    Strides Pharma arm gets tentative USFDA nod for skin ointment

    Medical Dialogues Bureau25 Jan 2020 12:04 PM IST
    New Delhi: Strides Pharma Science on Friday said its arm has received tentative nod from US health regulator for triamcinolone acetonide ointment used...
    Syngene International Limited announces Q3 FY20 results

    Syngene International Limited announces Q3 FY20 results

    Medical Dialogues Bureau25 Jan 2020 11:00 AM IST
    Reports 11% revenue growth in Q3 to Rs. 539 Cr
    Johnson & Johnson misses revenue estimates as blockbuster drugs disappoint

    Johnson & Johnson misses revenue estimates as blockbuster drugs disappoint

    Medical Dialogues Bureau24 Jan 2020 2:02 PM IST
    US: Johnson & Johnson narrowly missed quarterly revenue estimates on Wednesday as sales of its blockbuster psoriasis medicine Stelara and cancer...
    Wize Pharma Completes Patient Enrollment In Phase IV Study Of LO2A for the Treatment of Dry Eye Syndrome in Patients With Sjögrens Syndrome

    Wize Pharma Completes Patient Enrollment In Phase IV Study Of LO2A for the Treatment of Dry Eye Syndrome in Patients With Sjögren's Syndrome

    Medical Dialogues Bureau24 Jan 2020 11:31 AM IST
    Hod Hasharon: Wize Pharma a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced it has...
    FDA warns about potential cybersecurity vulnerabilities for certain GE Healthcare Clinical Information Central Stations and Telemetry Servers

    FDA warns about potential cybersecurity vulnerabilities for certain GE Healthcare Clinical Information Central Stations and Telemetry Servers

    Medical Dialogues Bureau24 Jan 2020 10:50 AM IST
    US: U.S. Food and Drug Administration is issuing a safety communication informing health care providers, facilities and patients about cybersecurity...
    Cipla gets USFDA observations for its Goa facility

    Cipla gets USFDA observations for its Goa facility

    Medical Dialogues Bureau23 Jan 2020 3:23 PM IST
    New Delhi: Drug firm Cipla on Wednesday said it has received observations from the USFDA for its Goa manufacturing facility. It further said that the...
    Alembic Pharma gets final USFDA nod for Fenofibrate tablets

    Alembic Pharma gets final USFDA nod for Fenofibrate tablets

    Medical Dialogues Bureau23 Jan 2020 2:56 PM IST
    New Delhi: Alembic Pharmaceuticals on Thursday said it has received final nod from the US health regulator for fenofibrate tablets, which reduces...
    Medicine shops remain shut across Bihar as pharmacist oppose new regulation

    Medicine shops remain shut across Bihar as pharmacist oppose new regulation

    Medical Dialogues Bureau23 Jan 2020 2:20 PM IST
    Bihar: Medicine shops remained shut across Bihar yesterday in protest against the state government's new regulation that calls for mandatory...
    Piramal Group to infuse Rs 500 crore in pharma operations in Telangana

    Piramal Group to infuse Rs 500 crore in pharma operations in Telangana

    Medical Dialogues Bureau23 Jan 2020 10:15 AM IST
    Hyderabad: Healthcare major Piramal Group has agreed to invest Rs 500 crore over the next three years in Telangana for setting up new facilities and...
    Japanese financial group MUFG sells 2.10pc shares in Cipla

    Japanese financial group MUFG sells 2.10pc shares in Cipla

    Medical Dialogues Bureau23 Jan 2020 10:00 AM IST
    "MUFG has sold an indirect interest in Cipla Ltd on account of sale of the following entities: First State Investment Management (UK) Ltd, First...
    Lupin Foundation Wins IDMA Corporate Citizen Award 2019

    Lupin Foundation Wins IDMA Corporate Citizen Award 2019

    Medical Dialogues Bureau23 Jan 2020 9:45 AM IST
    Mumbai: Pharma major Lupin Limited (Lupin) recently announced that its corporate social responsibility (CSR) arm, Lupin Foundation, has won the...
    Biocon Biologics gets Rs 536 crore investment from True North Fund

    Biocon Biologics gets Rs 536 crore investment from True North Fund

    Farhat Nasim22 Jan 2020 1:09 PM IST
    New Delhi: Biocon recently announced that Biocon Biologics India has received the subscription money aggregating to Rs. 536.25 crore from Activ Pine...
    PrevNext

    Popular Stories

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Lupin gets USFDA EIR for Nagpur Facility

    Lupin gets USFDA EIR for Nagpur Facility

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    KKRs Envision Healthcare hires bank to explore debt restructuring: Report

    KKR's Envision Healthcare hires bank to explore debt restructuring: Report

    Bioheaven gets USFDA go ahead to begin phase 2 trial of intranasal vazegepant to treat lung inflammation after COVID-19 infection

    Bioheaven gets USFDA go ahead to begin phase 2 trial of intranasal vazegepant to treat lung...

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok